Endotronix Stock

endotronix.comHealthcareFounded: 2007Funding to Date: $130.19MM

Endotronix is a digital health medtech company and developer of an integrated platform designed to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure.

Register for Details

For more details on financing and valuation for Endotronix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Endotronix.

Register Today


Management Team

Nicolas Chronos MD
Executive Vice President, Strategy & Clinical Affairs
Tyler Panian
Director of Mechanical Engineering
Michael Nagy
Co-Founder & Chief Technology Officer
Katrin Leadley MD
Chief Medical Officer
Harry Rowland Ph.D
Co-Founder, Chief Executive Officer & Board Member
John Flavin
Chief Financial Officer

Board Members

Harry Rowland Ph.D
Paul LaViolette
SV Health Investors
Stanley Lynall
OSF Ventures
Gerry Brunk
Lumira Ventures
James Hummer
Robert Zieserl
Fouad Azzam Ph.D
Life Sciences Partners
Jennifer McMahon
Seroba Life Sciences
Marc Goldberg JD
BioVentures Investors

Other companies like Endotronix in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


/PRNewswire/ -- Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion...
Endotronix said today that it closed on a $45 million Series D round for the Cordella cardiovascular monitoring technology it’s developing. The Lisle, Ill.-based company said its latest raise was led by LSP and included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments and an unnamed […]